Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism

ClinicalTrials.gov ID: NCT02730169

Public ClinicalTrials.gov record NCT02730169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of BGS649 in male obese subjects with hypogonadotropic hypogonadism. All subjects will be treated for a maximum of 24 weeks. Some subjects who complete 24 weeks of treatment will be invited to participate in a 6-month blinded safety extension study (Protocol MBGS206). The study is planned to enroll 268 subjects.

Study identification

NCT ID
NCT02730169
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mereo BioPharma
Industry
Enrollment
271 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 12, 2016 (Actual)
Primary completion
Feb 15, 2018 (Actual)
Completion
May 19, 2018 (Actual)
Last update posted
Sep 14, 2022

2016 – 2018

United States locations

U.S. sites
48
U.S. states
21
U.S. cities
48
Facility City State ZIP Site status
Mereo Research Site Birmingham Alabama — —
Mereo Research Site Mobile Alabama — —
Mereo Research Site Chandler Arizona — —
Mereo Research Site Phoenix Arizona — —
Mereo Research Site Scottsdale Arizona — —
Mereo Research Site Anaheim California — —
Mereo Research Site Carlsbad California — —
Mereo Research Site Greenbrae California — —
Mereo Research Site Lincoln California — —
Mereo Research Site Los Angeles California — —
Mereo Research Site San Diego California — —
Mereo Research Site Bradenton Florida — —
Mereo Research Site DeLand Florida — —
Mereo Research Site Fort Myers Florida — —
Mereo Research Site Hialeah Florida — —
Mereo Research Site Homestead Florida — —
Mereo Research Site St. Petersburg Florida — —
Mereo Research Site Meridian Idaho — —
Mereo Research Site Gurnee Illinois — —
Mereo Research Site Evansville Indiana — —
Mereo Research Site New Orleans Louisiana — —
Mereo Research Site Baltimore Maryland — —
Mereo Research Site Elkridge Maryland — —
Mereo Research Site St Louis Missouri — —
Mereo Research Site Omaha Nebraska — —
Mereo Research Site Henderson Nevada — —
Mereo Research Site Las Vegas Nevada — —
Mereo Research Site Albany New York — —
Mereo Research Site Garden City New York — —
Mereo Research Site Great Neck New York — —
Mereo Research Site New York New York — —
Mereo Research Site Rochester New York — —
Mereo Research Site Charlotte North Carolina — —
Mereo Research Site Raleigh North Carolina — —
Mereo Research Site Winston-Salem North Carolina — —
Mereo Research Site Middleburg Heights Ohio — —
Mereo Research Site Mt. Pleasant South Carolina — —
Mereo Research Site Nashville Tennessee — —
Mereo Research Site Smyrna Tennessee — —
Mereo Research Site Spring Hill Tennessee — —
Mereo Research Site Dallas Texas — —
Mereo Research Site Fort Worth Texas — —
Mereo Research Site Pearland Texas — —
Mereo Research Site San Antonio Texas — —
Mereo Research Site Murray Utah — —
Mereo Research Site West Jordan Utah — —
Mereo Research Site Norfolk Virginia — —
Mereo Research Site Kenosha Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02730169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02730169 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →